Management of Non-Muscle Invasive Bladder Cancer

Description

This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors. Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients. Front Matter ....Pages i-xxiv Front Matter ....Pages 1-1 Background on Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 3-3 Introduction to Bladder Cancer Type and Therapy (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 5-6 Front Matter ....Pages 7-7 Histological Variants in Bladder Cancer—Sqaumous Cell Carcinoma and Squamous Differentiation (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 9-10 Histological Variants in Bladder Cancer—Adenocarcinoma (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 11-15 Histological Variants in Bladder Cancer—Sarcomatoid Differentiation (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 17-19 Histological Variants in Bladder Cancer—Carcinosarcoma (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 21-25 Histological Variants in Bladder Cancer—Small Cell Carcinoma (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 27-34 Histological Variants—Plasmacytoid Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 35-41 Front Matter ....Pages 43-43 Introduction to Epidemiology of Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 45-47 Epidemiology, Risk Factors and Occupational Hazards—A Systematic Review (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 49-51 Systematic Review Results on Bladder Cancer Epidemiology, Occupational Hazards and Risk Factors (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 53-61 Front Matter ....Pages 63-63 Bladder Cancer—Diagnostic Pathways (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 65-67 Systematic Review Method—Bladder Cancer Screening (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 69-71 Bladder Cancer Screening—Systematic Review Results (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 73-98 Bladder Cancer Screening Systematic Review Conclusion (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 99-101 Statement of Main Findings and Specific Areas of Unmet Needs Arising from Systematic Review on Bladder Cancer Screening (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 103-104 Usefulness of Screening in Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 105-107 Front Matter ....Pages 109-109 Management of Non-Muscle Invasive Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 111-113 A New Technique—En Bloc Resection of Bladder Tumours (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 115-116 Prognostic Factors for Endoscopic Resection in NMIBC (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 117-118 NMIBC and Oncological Outcomes from Endoscopic Resection (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 119-120 Recurrence in NMIBC (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 121-122 Definitive Treatment in NMIBC (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 123-124 A Systematic Review of En-Bloc Resection (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 125-127 Systematic Review—Results from En-Bloc Resection of Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 129-139 Front Matter ....Pages 141-141 NMIBC—Fulguration in Low Risk Disease (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 143-144 Active Surveillance in Non-Muscle Invasive Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 145-150 Hyperthermic MMC—A Systematic Review (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 151-164 Literature Related to Hyperthermic MMC (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 165-166 Front Matter ....Pages 167-167 BCG—Patterns of Administration (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 169-170 NMIBC—BCG Strain and Outcomes (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 171-172 Adverse Effects in BCG Therapy (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 173-174 BCG and Elderly Patients (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 175-179 A Systematic Review of NMIBC and Intravesical Chemotherapy (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 181-183 A Systematic Review of NMIBC and Intravesical Chemotherapy—Results (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 185-196 What the Literature Says Re BCG (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 197-199 Prognostic Factors in BCG (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 201-202 Intermediate and High Risk NMIBC and BCG (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 203-204 NMIBC, Low Dose BCG and High-Risk Disease (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 205-206 Alternatives to BCG Therapy—MMC (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 207-208 BCG Versus Mitomycin C—A Systematic Review (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 209-220 What the Literature Says NMIBC—BCG or MMC (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 221-222 NMIBC and Intravesical Chemotherapy—HIVEC I and HIVEC II (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 223-224 BCG Refractory Disease—Oncological Outcomes (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 225-227 NMIBC—High Grade BCG Refractory Disease (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 229-231 A Systematic Review on Alternatives in BCG Refractory Disease (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 233-234 Systematic Review Results on BCG Refractory Disease Management (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 235-249 What the Literature Says on BCG Refractory Disease and Alternatives (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 251-252 NMIBC—BCG Refractory Disease and Use of Interferon (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 253-253 Novel Agents in BCG Refractory Disease (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 255-259 A Scoring System for Intravesical Therapy and NMIBC (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 261-261 High Risk NMIBC and TURBT (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 263-264 G3T1 Bladder Cancer: Cystectomy Versus BCG (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 265-267 A Systematic Review of High-Grade Bladder Cancer—Methods (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 269-270 Systematic Review of G3T1 Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 271-281 Radical Cystectomy in High Grade NMI Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 283-284 Front Matter ....Pages 285-285 Bladder Cancer in the Elderly (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 287-290 Systematic Review on Bladder Cancer Management in Elderly Patients (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 291-293 Systematic Review—Results on Bladder Cancer Management in the Elderly (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 295-306 Reviews Relating to Management of Bladder Cancer in the Elderly (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 307-309 Female Outcomes in Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 311-312 A Systematic Review on Bladder Cancer and Female Gender (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 313-314 Systematic Review Results on Bladder Cancer and Female Gender (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 315-320 Reviews on Female Gender and Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 321-322 Front Matter ....Pages 323-323 Definition of Bladder Cancer Survivorship (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 325-326 The Impact of Bladder Cancer Survivorship (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 327-327 Unmet Needs in Bladder Cancer Survivorship (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 329-330 Systematic Review—Bladder Cancer Survivorship—Unmet Needs (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 331-332 Systematic Review Search Results—Bladder Cancer Survivorship and Unmet Need (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 333-340 Survivorship Challenges in Non-Muscle Invasive Bladder Cancer (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 341-343 Bladder Cancer Survivorship Care Plans (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 345-347 Research Summary—A New Model of Care for Patients with Bladder Cancer (MODA) (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 349-351 What Is the Impact of Sexual and Emotional Concerns on Patients Post Surgery for Patients with Bladder Cancer? (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 353-354 Results—Telephone Interviews with Thematic Analyses (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 355-355 Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 1 Erectile Dysfunction (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 357-358 Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 2 Age Related Disease (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 359-359 Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 3 Side Effects Post Operatively (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 361-362 Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 4 Psychological Impact (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 363-363 Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 5 Impact of Operation on General Health (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 365-365 Bladder Cancer Survivorship Tool (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 367-369 Health Related Quality of Life Measurements in Bladder Cancer Survivorship (Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala)....Pages 371-374 Back Matter ....Pages 375-402